Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Weather
56 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Just In
Missing boy: Body of 16-year-old boy with autism recovered after going missing in Neuse River, Kinston police say
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by DIAGONAL THERAPEUTICS, INC
Diagonal Therapeutics Announces Publication of Data Characterizing the Healthcare System Cost and Impact of Hereditary Hemorrhagic Telangiectasia (HHT) in the American Journal of Hematology
July 10, 2025
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics Appoints John Lee, M.D., Ph.D., as Chief Medical Officer
July 08, 2025
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal’s First-in-Class Clustering Antibody, DIAG723, Receives Orphan Drug Designation (ODD) from U.S. FDA and an ODD Positive Opinion from EMA for Treatment of Hereditary Hemorrhagic Telangiectasia (HHT)
June 18, 2025
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of Receptor Clustering Antibody Approach in HHT at EHA 2025 Congress
June 12, 2025
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics Initiates Natural History Study of Adults Living with Hereditary Hemorrhagic Telangiectasia (HHT), a Rare Bleeding Disorder with No Approved Treatments
March 04, 2025
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics to Present Data at ASH 2024 Demonstrating the Economic and Clinical Burden of Hereditary Hemorrhagic Telangiectasia (HHT)
December 03, 2024
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics to Present at the Cure HHT’s 15th International Scientific Conference
October 08, 2024
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases
April 03, 2024
From
DIAGONAL THERAPEUTICS, INC
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.